Similar articles

• A probiotics trial on trial: the problem of timely detection of adverse advents in therapeutic trials.

  Giard RW. Giard RW. J Clin Epidemiol. 2010 Apr;63(4):347-9. doi: 10.1016/j.jclinepi.2008.12.012. Epub 2009 Sep 17. J Clin Epidemiol. 2010. PMID: 19762211 No abstract available.
• Current controversies in data monitoring for clinical trials.

  Pocock SJ. Pocock SJ. Clin Trials. 2006;3(6):513-21. doi: 10.1177/1740774506073467. Clin Trials. 2006. PMID: 17170035
• The many moral responsibilities of independent data-monitoring committees.

  Braillon A. Braillon A. Am J Bioeth. 2011 Mar;11(3):16-7. doi: 10.1080/15265161.2010.546475. Am J Bioeth. 2011. PMID: 21400378 No abstract available.
• Randomized trials in oncology stopped early for benefit.

  Wilcox RA, Djulbegovic B, Moffitt HL, Guyatt GH, Montori VM. Wilcox RA, et al. J Clin Oncol. 2008 Jan 1;26(1):18-9. doi: 10.1200/JCO.2007.13.6259. J Clin Oncol. 2008. PMID: 18165635 Review. No abstract available.
• Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal.

  Dechartres A, Boutron I, Roy C, Ravaud P. Dechartres A, et al. J Clin Epidemiol. 2009 Jul;62(7):695-702. doi: 10.1016/j.jclinepi.2008.09.011. Epub 2009 Jan 9. J Clin Epidemiol. 2009. PMID: 19135860 Review.